These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16629599)

  • 1. The intensive care unit as a research laboratory: developing strategies to prevent antimicrobial resistance.
    Kollef MH
    Surg Infect (Larchmt); 2006 Apr; 7(2):85-99. PubMed ID: 16629599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies to prevent antimicrobial resistance in the intensive care unit.
    Kollef MH; Micek ST
    Crit Care Med; 2005 Aug; 33(8):1845-53. PubMed ID: 16096464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit?
    Kollef MH
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S82-8. PubMed ID: 16894520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic resistance in the intensive care unit.
    Kollef MH; Fraser VJ
    Ann Intern Med; 2001 Feb; 134(4):298-314. PubMed ID: 11182841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bench-to-bedside review: antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit.
    Kollef MH
    Crit Care; 2005 Oct; 9(5):459-64. PubMed ID: 16277734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The intensive care unit in antimicrobial resistance.
    Koleff MH
    Postgrad Med; 2001 Feb; 109(2 Suppl):60-9. PubMed ID: 19667559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of resistant microbes in critical care units is transient, despite an unrestricted formulary and multiple antibiotic trials.
    Franklin GA; Moore KB; Snyder JW; Polk HC; Cheadle WG
    Surg Infect (Larchmt); 2002; 3(2):135-44. PubMed ID: 12519480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial stewardship in the intensive care unit: a focus on potential pitfalls.
    Njoku JC; Hermsen ED
    J Pharm Pract; 2010 Feb; 23(1):50-60. PubMed ID: 21507793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance: factors and outcomes.
    Fish DN; Ohlinger MJ
    Crit Care Clin; 2006 Apr; 22(2):291-311, vii. PubMed ID: 16678001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions to prevent transmission of antimicrobial-resistant bacteria in the intensive care unit.
    Huskins WC
    Curr Opin Crit Care; 2007 Oct; 13(5):572-7. PubMed ID: 17762238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy.
    Ramsamy Y; Muckart DJ; Han KS
    S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of programs to decrease antimicrobial resistance in the intensive care unit.
    Hall CS; Ost DE
    Semin Respir Infect; 2003 Jun; 18(2):112-21. PubMed ID: 12840792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial resistance in intensive care units.
    Fridkin SK; Gaynes RP
    Clin Chest Med; 1999 Jun; 20(2):303-16, viii. PubMed ID: 10386258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of susceptibility to beta-lactam antimicrobial agents among bacteria isolated from intensive care units.
    Pierson CL; Friedman BA
    Diagn Microbiol Infect Dis; 1992 Feb; 15(2 Suppl):19S-30S. PubMed ID: 1737439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the infectious diseases specialist consultant on the appropriateness of antimicrobial therapy prescription in an intensive care unit.
    Raineri E; Pan A; Mondello P; Acquarolo A; Candiani A; Crema L
    Am J Infect Control; 2008 May; 36(4):283-90. PubMed ID: 18455049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlling antimicrobial resistance in the hospital.
    Anderson DJ; Kaye KS
    Infect Dis Clin North Am; 2009 Dec; 23(4):847-64, vii-viii. PubMed ID: 19909887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of an intensive care unit rotating empiric antibiotic schedule on the development of hospital-acquired infections on the non-intensive care unit ward.
    Hughes MG; Evans HL; Chong TW; Smith RL; Raymond DP; Pelletier SJ; Pruett TL; Sawyer RG
    Crit Care Med; 2004 Jan; 32(1):53-60. PubMed ID: 14707559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011).
    Sader HS; Farrell DJ; Flamm RK; Jones RN
    Diagn Microbiol Infect Dis; 2014 Apr; 78(4):443-8. PubMed ID: 24492025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal changes in bacterial resistance in German intensive care units, 2001-2003: data from the SARI (surveillance of antimicrobial use and antimicrobial resistance in intensive care units) project.
    Meyer E; Schwab F; Jonas D; Ruden H; Gastmeier P; Daschner FD
    J Hosp Infect; 2005 Aug; 60(4):348-52. PubMed ID: 15923060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genodiversity of resistant Pseudomonas aeruginosa isolates in relation to antimicrobial usage density and resistance rates in intensive care units.
    Jonas D; Meyer E; Schwab F; Grundmann H
    Infect Control Hosp Epidemiol; 2008 Apr; 29(4):350-7. PubMed ID: 18269329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.